About Gesundheitszentrum Holzminden
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gesundheitszentrum Holzminden
During the past decade, Gesundheitszentrum Holzminden conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
2014-06-01
2023-12-31
Recruiting
126
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-07-23
2019-02-27
Completed
387
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
2016-07-25
2020-01-29
Completed
509
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
2017-09-29
2021-04-07
Terminated
50
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
2017-07-20
2019-02-05
Terminated
119
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
2018-07-13
2019-10-21
Completed
233
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Gesundheitszentrum Holzminden"
#1 collaborator was "OnkoDataMed GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Gesundheitszentrum Holzminden
According to Clinical.Site data, the most researched conditions in "Gesundheitszentrum Holzminden" are
"Cancer" (1 trials), "Locally Advanced Renal Cell Carcinoma" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Gesundheitszentrum Holzminden" in a lesser frequency.
Clinical Trials Intervention Types at Gesundheitszentrum Holzminden
Most popular intervention types in "Gesundheitszentrum Holzminden" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone Acetate" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Pazopanib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gesundheitszentrum Holzminden
The vast majority of trials in "Gesundheitszentrum Holzminden" are
2 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at Gesundheitszentrum Holzminden
Currently, there are NaN active trials in "Gesundheitszentrum Holzminden".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Gesundheitszentrum Holzminden,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gesundheitszentrum Holzminden, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".